Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Iran J Med Sci. 2024 Apr 1;49(4):247-258. doi: 10.30476/IJMS.2023.97708.2951. eCollection 2024 Apr.
Even though a few years have passed since the coronavirus disease 2019 (COVID-19) outbreak, information regarding certain aspects of the disease, such as post-infection immunity, is still quite limited. This study aimed to evaluate post-infection protection and COVID-19 features among healthcare workers (HCWs), during three successive surges, as well as the rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection, reactivation, re-positivity, and severity.
This cross-sectional population-level observational study was conducted from 20 April 2020 to 18 February 2021. The study population included all HCWs in public or private hospitals in Fars Province, Southern Iran. The infection rate was computed as the number of individuals with positive polymerase chain reaction (PCR) tests divided by the total number of person-days at risk. The re-infection was evaluated after 90 days.
A total of 30,546 PCR tests were performed among HCWs, of which 13,749 (61.94% of total HCWs) were positive. Considering the applied 90-day threshold, there were 44 (31.2%) cases of reactivation and relapse, and 97 (68.8% of infected and 1.81% of total HCWs) cases of reinfection among 141 (2.64%) diagnosed cases who experienced a second episode of COVID-19. There was no significant difference in symptoms (P=0.65) or the necessity for ICU admission (P=0.25). The estimated protection against repeated infection after a previous SARS-CoV-2 infection was 94.8% (95% CI=93.6-95.7).
SARS-CoV-2 re-positivity, relapse, and reinfection were rare in the HCW population. After the first episode of infection, an estimated 94.8% protection against recurring infections was achieved. A preprint version of this manuscript is available at DOI:10.21203/rs.3.rs-772662/v1 (https://www.researchsquare.com/article/rs-772662/v1).
尽管自 2019 年冠状病毒病(COVID-19)爆发以来已经过去了几年,但有关该病的某些方面的信息,如感染后免疫,仍然相当有限。本研究旨在评估连续三次疫情期间医护人员(HCWs)的感染后保护和 COVID-19 特征,以及严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)再感染、再激活、再阳性和严重程度的发生率。
这项横断面人群观察性研究于 2020 年 4 月 20 日至 2021 年 2 月 18 日进行。研究人群包括伊朗南部法尔斯省所有公立或私立医院的 HCWs。感染率的计算方法为阳性聚合酶链反应(PCR)检测的个体数除以感染风险的总人天数。在 90 天后评估再感染。
共对 HCWs 进行了 30546 次 PCR 检测,其中 13749 次(总 HCWs 的 61.94%)为阳性。考虑到应用的 90 天阈值,在 141 例(2.64%)诊断为 COVID-19 的第二例患者中,有 44 例(31.2%)出现再激活和复发,97 例(感染的 68.8%和总 HCWs 的 1.81%)出现再感染。在症状(P=0.65)或入住 ICU 的必要性(P=0.25)方面无显著差异。既往 SARS-CoV-2 感染后重复感染的估计保护率为 94.8%(95%CI=93.6-95.7)。
在 HCW 人群中,SARS-CoV-2 再阳性、复发和再感染罕见。在首次感染后,估计对再次感染的保护率为 94.8%。该手稿的预印本可在 DOI:10.21203/rs.3.rs-772662/v1(https://www.researchsquare.com/article/rs-772662/v1)获得。